Trial NCT01071564

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2012-02064
Secondary IDs: 2009-099 8420 CDR0000662081 NCI-2012-02064 P30CA022453 U01CA062487 U01CA070095

Last trial update was posted on 2015-04-15

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide Gamma Secretase Inhibitors and Modulators

MeSH Conditions

Breast Neoplasms Carcinoma

Other Conditions

Estrogen Receptor Negative HER2/Neu Negative Progesterone Receptor Negative Recurrent Breast Carcinoma Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer Triple-Negative Breast Carcinoma

Stopping Reasons

N/A

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID